Press releases | WebDisclosure

Basculer en Français

10168	Companies
209030	Keywords
139147	Articles
110808	Press releases

Home
Press releases

PRESS RELEASE

published on 01/23/2026 at 08:00, 2 months 15 days ago

BIGBEN: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publication mensuelle du nombre total de droits de vote et d'actions composant le capital social conformément à l'article 223-16 du Règlement Général de l'Autorité des Marchés Financiers

Autorité Des Marchés Financiers Euronext Paris Droits De Vote Capital Social Publication Mensuelle
PRESS RELEASE

published on 01/23/2026 at 08:00, 2 months 15 days ago

Transgene renforce son comité scientifique avec l’arrivée d’Antoine Italiano et Ignacio Melero, deux experts renommés en immunothérapie du cancer
Transgene renforce son comité scientifique avec l’arrivée d’Antoine Italiano et Ignacio Melero, experts en immunothérapie du cancer. Ils apporteront une expertise considérable à Transgene pour accélérer le développement de vaccins thérapeutiques anticancéreux

Immunothérapie Cancer Transgene Comité Scientifique Experts
PRESS RELEASE

published on 01/23/2026 at 08:00, 2 months 15 days ago

Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

MANAGEMENT STATEMENT FOR THE THIRD QUARTER ENDED 31 DECEMBER 2025
Reinet Investments S.C.A. announces the results for the third quarter ended 31 December 2025 in a management statement. The company is listed on multiple stock exchanges

Shareholders Quarter Results Investment Fund Luxembourg Stock Exchange Reinet Investments
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

Mikron reports net sales of CHF 381.9 million for 2025
Mikron reports a 2.1% increase in net sales to CHF 381.9 million for 2025. Operating profit margin expected to be around 10.4%. Order backlog declines by 14.8% for 2026

Financial Results Net Sales Order Backlog Operating Profit Margin Mikron
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit
BB Biotech AG closes the 2025 fiscal year with a profit of approximately CHF 578 million, reflecting share price development. Full report on Feb 20, 2026

BB Biotech AG Profit 2025 Fiscal Year Share Price Development CHF 578 Million
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

BB Biotech: Preliminary full-year 2025 results and dividend proposal
BB Biotech AG reports strong full-year 2025 results with +34.2% total return in CHF, +37.0% in EUR, and +53.7% in USD, proposes dividend of CHF 2.25 per share at AGM on March 19, 2026

Dividend Proposal Stock Market Full-year Results BB Biotech AG 2025 Performance
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

VALLOUREC PRÉSENTERA DELPHY, SA SOLUTION INNOVANTE DE STOCKAGE D’HYDROGÈNE, À HYVOLUTION 2026
Vallourec présente Delphy, sa solution innovante de stockage d'hydrogène, au salon Hyvolution 2026, Paris. Delphy, lauréat du Prix de l'Innovation, offre une solution de stockage souterrain d'hydrogène gazeux

Innovation Stockage Hydrogène Vallourec Delphy
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

VALLOUREC TO SHOWCASE DELPHY, ITS INNOVATIVE HYDROGEN STORAGE SOLUTION, AT HYVOLUTION 2026
Vallourec to showcase Delphy, its innovative hydrogen storage solution, at Hyvolution 2026. Delphy awarded Innovation Prize. Event provides platform for green hydrogen solutions

Innovation Award Hydrogen Storage Vallourec Delphy Hyvolution 2026
PRESS RELEASE

published on 01/23/2026 at 07:00, 2 months 15 days ago

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
Sanofi's amlitelimab shows potential in atopic dermatitis with positive results in SHORE and COAST 2 phase 3 studies. Global regulatory submissions planned

Sanofi Phase 3 Study Atopic Dermatitis Global Regulatory Submissions Amlitelimab

Accesswire

Published on 04/07/2026 at 15:00, 5 hours 27 minutes ago

Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 5 hours 42 minutes ago

Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 5 hours 47 minutes ago

bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 5 hours 57 minutes ago

Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 5 hours 57 minutes ago

Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board

View all ACCESSWIRE

EQS Group

Published on 04/07/2026 at 19:30, 57 minutes ago

Stabilisation Notice
Published on 04/07/2026 at 17:45, 2 hours 42 minutes ago

VAZIVA SA: Mise à jour des modalités de l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Published on 04/07/2026 at 17:45, 2 hours 42 minutes ago

FIGEAC AÉRO: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2026 at 17:40, 2 hours 47 minutes ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 04/07/2026 at 16:32, 3 hours 55 minutes ago

Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.

Les Echos

Published on 04/07/2026 at 18:00, 2 hours 27 minutes ago

LDC : Chiffre d’affaires du 4 ème trimestre 2025-2026. Solide croissance du chiffre d’affaires au 4ème trimestre 2025-2026 et révision à la hausse des objectifs.
Published on 04/07/2026 at 17:57, 2 hours 30 minutes ago

Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:57, 2 hours 30 minutes ago

Mise à disposition du Document d’enregistrement universel 2025
Published on 04/07/2026 at 17:45, 2 hours 42 minutes ago

ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:45, 2 hours 42 minutes ago

ENGIE accélère le déploiement du stockage par batteries avec près de 400 MW de nouveaux projets en Europe

View all LES ECHOS COMFI WIRE